SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013083
Filing Date
2022-05-12
Accepted
2022-05-12 17:08:46
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1077554
2 ex31-1.htm EX-31.1 19046
3 ex31-2.htm EX-31.2 19084
4 ex32-1.htm EX-32.1 9257
5 ex32-2.htm EX-32.2 9484
  Complete submission text file 0001493152-22-013083.txt   5914185

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20220331.xsd EX-101.SCH 44311
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ensc-20220331_cal.xml EX-101.CAL 54107
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20220331_def.xml EX-101.DEF 220350
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20220331_lab.xml EX-101.LAB 380211
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20220331_pre.xml EX-101.PRE 309951
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 966763
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 22918897
SIC: 2834 Pharmaceutical Preparations